deferiprone has been researched along with Reperfusion Injury in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Thapa, K | 1 |
| Singh, TG | 1 |
| Kaur, A | 1 |
| Reuter, DG | 1 |
| Tacker, WA | 1 |
| Babbs, CF | 1 |
| Badylak, SF | 1 |
| Voorhees, WD | 1 |
| Konrad, PE | 1 |
| Moridani, MY | 1 |
| O'Brien, PJ | 1 |
1 review available for deferiprone and Reperfusion Injury
| Article | Year |
|---|---|
Targeting ferroptosis in ischemia/reperfusion renal injury.
Topics: Deferasirox; Deferiprone; Ferroptosis; Humans; Iron; Iron Chelating Agents; Ischemia; Kidney; Pharma | 2022 |
2 other studies available for deferiprone and Reperfusion Injury
| Article | Year |
|---|---|
Preliminary results of deferoxamine and L1 treatment of spinal cord ischemia.
Topics: Animals; Deferiprone; Deferoxamine; Dogs; Iron Chelating Agents; Ischemia; Pyridones; Reperfusion In | 1995 |
Iron complexes of deferiprone and dietary plant catechols as cytoprotective superoxide radical scavengers(1).
Topics: Animals; Antioxidants; Catechols; Copper; Deferiprone; Disease Models, Animal; Free Radical Scavenge | 2001 |